Key result
Obstructive sleep apnea is a significant risk factor for developing systemic arterial hypertension, driven by cyclical oxygen desaturation and sympathetic hyperactivity.
Why the study?
OSA is an important risk factor for developing hypertension, prompting a review to present updated knowledge of their relationship and pathogenic association.
Obstructive sleep apnea is a critical, often underdiagnosed contributor to systemic arterial hypertension, and its targeted management can improve blood pressure control and overall cardiovascular health.
Obstructive sleep apnea (OSA) is a prevalent sleep disorder that impacts a considerable proportion of people around the world, and is often associated with other health conditions including obesity, diabetes and cardiovascular diseases. OSA is an important risk factor for developing hypertension as it leads to cyclical oxygen desaturation, sympathetic hyperactivity, poor sleep quality, frequent microarousals and daytime drowsiness. This review aims to present updated knowledge of the relationship and pathogenic association between sleep apnea and hypertension.
No takes yet. Share an insight, caveat, or question.
Leon et al. (2024) conducted a review in Obstructive sleep apnea and systemic arterial hypertension. Obstructive sleep apnea vs. No obstructive sleep apnea was evaluated on Development of systemic arterial hypertension. Obstructive sleep apnea is a significant risk factor for developing systemic arterial hypertension, driven by cyclical oxygen desaturation and sympathetic hyperactivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: